Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial

Clinical trial NCT04332666 · UNKNOWN

Trial details

NCT number: NCT04332666
Sponsor: Erasme University Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Coronavirus Respiratory Failure Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere SARS-CoV-2

Start date: 2021-12-30
Primary completion: 2022-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.